PCR Technologies for Point of Care Testing: Progress and Perspectives

• Published in: ACS sensors Vol. 2; no. 7; pp. 876 - 891
• Main Authors: Petralia, Salvatore, Conoci, Sabrina
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 28.07.2017
• Subjects: PoC; lab-on-chips; fully integrated systems; labeled-probes; sample prep; nucleic acids; PCR; electrical transduction; intercalating agents
• ISSN: 2379-3694; 2379-3694
• DOI: 10.1021/acssensors.7b00299

Since the Human Genome Project completed in 2000, the sequencing of the first genome, massive progress has been made by medical science in the early diagnosis and personalized therapies based on nucleic acids (NA) analysis. To allow the extensive use of these molecular methods in medical practice, scientific research is nowadays strongly focusing on the development of new miniaturized and easy-to-use technologies and devices allowing fast and low cost NA analysis in decentralized environments. It is now the era of so-called genetic “Point-of-Care” (PoC). These systems must integrate and automate all steps necessary for molecular analysis such as sample preparation (extraction and purification of NA) and detection based on PCR (Polymerase Chain Reaction) technology in order to perform, by unskilled personnel, in vitro genetic analysis near the patient (in hospital, in the physician office, clinic, or home), with rapid answers and low cost. In this review, the recent advances in genetic PoC technologies are discussed, including the extraction and PCR amplification chemistry suitable for PoC use and the new frontiers of research in this field.